Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle

Taylor, R.S., Drummond, M.F., Salkeld, G. et al. (1 more author) (2004) Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ, 329 (7472). pp. 972-975. ISSN 0959-8146

Abstract

Metadata

Authors/Creators:
  • Taylor, R.S.
  • Drummond, M.F.
  • Salkeld, G.
  • Sullivan, S.D.
Institution: The University of York
Academic Units: The University of York > Centre for Health Economics (York)
Depositing User: Repository Officer
Date Deposited: 14 Nov 2008 18:14
Last Modified: 14 Nov 2008 18:19
Published Version: http://dx.doi.org/10.1136/bmj.329.7472.972
Status: Published
Publisher: BMJ Publishing
Refereed: Yes
Identification Number: https://doi.org/10.1136/bmj.329.7472.972

Share / Export

Statistics